Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 296 record(s)

Req # A-2021-025

“Provide the following briefing documents prepared in May 2021: C21-2422 Implementation of InfoCollab Cafés; E21-0579 Annual Report - Meeting with the Leader of the Official Opposition of Canada and the leader of the Conservative Party of Canada.”

Organization: Office of the Commissioner of Official Languages

6 page(s)
July 2021

Req # A-2021-11082

Copies of all documents presented, and shared with participants related to the symposium organized by the PMPRB with academics during the week of May 31, 2021.

Organization: Patented Medicine Prices Review Board Canada

207 page(s)
July 2021

Req # A-2021-003

“From January 1, 2011 to December 31, 2019, provide data or reports on the level of Code 699 usage prior to the pandemic; i.e. information showing the level of Code 699 usage in the federal public service, by department. Limit records to final version or last available draft. Exclude records that may require consult with DOJ to confirm possible cabinet confidences.”

Organization: Office of the Commissioner of Official Languages

0 page(s)
June 2021

Req # A-2021-09955

Copy of the French version of the February 9, 2021 communication plan titled "Modern and Proactive Communications Strategy".

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
June 2021

Req # A-2021-11663

A copy of the release package that was disclosed in response to access to information request file number A-2021-007891.

Organization: Patented Medicine Prices Review Board Canada

95 page(s)
June 2021

Req # A-2021-11666

A copy of the PMPRB's 6-page Communication Plan, "Modern and Proactive Communications Strategy", dated February 9, 2021 as previously disclosed in a release package in response to an access to information request.

Organization: Patented Medicine Prices Review Board Canada

6 page(s)
June 2021

Req # A-2021-11668

Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.

Organization: Patented Medicine Prices Review Board Canada

3 page(s)
June 2021

Req # A-2021-002

1. The Policy on Language Complaints by OCOL Staff (the most recent version, in its entirety, including the incident form related to this policy). 2. The Policy on the Filing of Complaints by OCOL Staff (the 2018, 2020 and most recent versions, in their entirety, including the incident forms related to these policies). 3. The entirety of the key messages sent to staff in response to the recent leak of personal IP address information.

Organization: Office of the Commissioner of Official Languages

49 page(s)
May 2021

Req # A-2021-07238

Copies of all information, data, document, or correspondence concerning the PMPRB's classification of the following drug products: NOVORAPID and FIASP, each a product of NOVO NORDISK CANADA INC, a corporation located at 101-2476 Argentia Road, Mississauga, Ontario, Canada L5N 6M1, including but not limited to classifications based on drug product line extensions, similar chemical entities, comparable dosages, or a reasonable relationship between the two drugs, as well as any other analysis, comments, or information related to the classification of these two drugs.

Organization: Patented Medicine Prices Review Board Canada

12 page(s)
May 2021

Req # A-2021-07885

Copies of all briefing notes provided to the Deputy Minister regarding the implementation of the new PMPRB guidelines on July 1, 2021 from January 1, 2021 to April 28, 2021.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
May 2021
Date modified: